ebomi
Colour theme
Sign in
Insider · CIK 0001388325

Novo Holdings A/S

CIK 0001388325 Name as filed on the most recent filing

Filed as Novo Holdings A/S (66)· Novo A/S (69)

724 transaction lines · from 135 filings · filed 2007-02-02 to 2026-05-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised. The 40 most recent are shown; the catalog may hold more for this insider.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

724 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2017-08-07 S, Open-market sale Anaptysbio IncANAB 23,443, disposed Open Form 4 filing 0001209191-17-048152
2017-08-04 S, Open-market sale Anaptysbio IncANAB 225,963, disposed Open Form 4 filing 0001209191-17-048152
2017-08-03 S, Open-market sale Anaptysbio IncANAB 472,192, disposed Open Form 4 filing 0001209191-17-047444
2017-08-02 S, Open-market sale Anaptysbio IncANAB 613,485, disposed Open Form 4 filing 0001209191-17-047444
2017-08-01 S, Open-market sale Anaptysbio IncANAB 562,270, disposed Open Form 4 filing 0001209191-17-047444
2017-07-26 S, Open-market sale Apollo Endosurgery, Inc.APEN 57,643, disposed Open Form 4 filing 0001209191-17-046365
2017-07-25 S, Open-market sale Apollo Endosurgery, Inc.APEN 170,585, disposed Open Form 4 filing 0001209191-17-046365
2017-07-24 S, Open-market sale Apollo Endosurgery, Inc.APEN 117,538, disposed Open Form 4 filing 0001209191-17-046365
2017-06-23 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 219,000, acquired Open Form 4 filing 0001209191-17-041961
2017-06-14 S, Open-market sale Reata Pharmaceuticals IncRETA 1,241,853, disposed Open Form 4 filing 0001209191-17-039847
2017-06-13 S, Open-market sale Reata Pharmaceuticals IncRETA 290,073, disposed Open Form 4 filing 0001209191-17-039847
2017-06-12 S, Open-market sale Reata Pharmaceuticals IncRETA 2,282,824, disposed Open Form 4 filing 0001209191-17-039273
2017-06-09 S, Open-market sale Reata Pharmaceuticals IncRETA 56,955, disposed Open Form 4 filing 0001209191-17-039273
2017-06-08 S, Open-market sale Reata Pharmaceuticals IncRETA 3,380,000, disposed Open Form 4 filing 0001209191-17-039273
2017-06-07 S, Open-market sale Reata Pharmaceuticals IncRETA 56,079, disposed Open Form 4 filing 0001209191-17-038421
2017-06-06 S, Open-market sale Reata Pharmaceuticals IncRETA 1,802,490, disposed Open Form 4 filing 0001209191-17-038421
2017-06-05 S, Open-market sale Reata Pharmaceuticals IncRETA 668,825, disposed Open Form 4 filing 0001209191-17-038421
2017-05-11 S, Open-market sale Apollo Endosurgery, Inc.APEN 582,094, disposed Open Form 4 filing 0001209191-17-031598
2017-05-10 S, Open-market sale Apollo Endosurgery, Inc.APEN 8,609, disposed Open Form 4 filing 0001209191-17-031598
2017-01-31 P, Open-market purchase Anaptysbio IncANAB 750,000, acquired Open Form 4 filing 0001209191-17-006695
2016-12-15 S, Open-market sale Ophthotech Corp.OPHT 6,636,007, disposed Open Form 4 filing 0001209191-16-155715
2016-12-14 S, Open-market sale Ophthotech Corp.OPHT 10,962,378, disposed Open Form 4 filing 0001209191-16-155715
2016-10-31 P, Open-market purchase Ra Pharmaceuticals, Inc.RARX 3,200,002, acquired Open Form 4 filing 0001209191-16-147941
2016-10-25 P, Open-market purchase iRhythm Technologies, Inc.IRTC 1,700,000, acquired Open Form 4 filing 0001209191-16-147005
2016-09-09 P, Open-market purchase CoLucid Pharmaceuticals, Inc.CLCD 2,000,000, acquired Open Form 4 filing 0001209191-16-141046
2016-07-13 S, Open-market sale Tobira Therapeutics, Inc.TBRA 354,944, disposed Open Form 4 filing 0001209191-16-132637
2016-07-12 S, Open-market sale Tobira Therapeutics, Inc.TBRA 106,072, disposed Open Form 4 filing 0001209191-16-132637
2016-07-11 S, Open-market sale Tobira Therapeutics, Inc.TBRA 249,101, disposed Open Form 4 filing 0001209191-16-132637
2016-07-07 S, Open-market sale Tobira Therapeutics, Inc.TBRA 263,150, disposed Open Form 4 filing 0001209191-16-132076
2016-07-06 S, Open-market sale Tobira Therapeutics, Inc.TBRA 730,272, disposed Open Form 4 filing 0001209191-16-132076
2016-07-05 S, Open-market sale Tobira Therapeutics, Inc.TBRA 130,709, disposed Open Form 4 filing 0001209191-16-132076
2016-06-30 S, Open-market sale Tobira Therapeutics, Inc.TBRA 341,368, disposed Open Form 4 filing 0001209191-16-130277
2016-06-29 S, Open-market sale Tobira Therapeutics, Inc.TBRA 202,947, disposed Open Form 4 filing 0001209191-16-130277
2016-06-28 S, Open-market sale Tobira Therapeutics, Inc.TBRA 2 lines 326,626, disposed Open Form 4 filing 0001209191-16-130277
2016-06-06 S, Open-market sale Tobira Therapeutics, Inc.TBRA 1,943,906, disposed Open Form 4 filing 0001209191-16-126301
2016-06-01 P, Open-market purchase Reata Pharmaceuticals IncRETA 8,250,000, acquired Open Form 4 filing 0001209191-16-125079
2016-05-24 S, Open-market sale Ophthotech Corp.OPHT 63,700,000, disposed Open Form 4 filing 0001209191-16-123286
2016-05-12 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 700,000, acquired Open Form 4 filing 0001209191-16-120415
2016-03-29 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 9,999,990, acquired Open Form 4 filing 0001209191-16-111003
2016-03-04 S, Open-market sale Tobira Therapeutics, Inc.TBRA 359,667, disposed Open Form 4 filing 0001209191-16-106218
2016-03-03 S, Open-market sale Tobira Therapeutics, Inc.TBRA 171,395, disposed Open Form 4 filing 0001209191-16-106218
2016-03-02 S, Open-market sale Tobira Therapeutics, Inc.TBRA 761,024, disposed Open Form 4 filing 0001209191-16-106218
2015-11-18 S, Open-market sale Tobira Therapeutics, Inc.TBRA 1,498,685, disposed Open Form 4 filing 0001209191-15-081356
2015-11-17 S, Open-market sale Tobira Therapeutics, Inc.TBRA 704,394, disposed Open Form 4 filing 0001209191-15-081356
2015-06-22 S, Open-market sale Flexion Therapeutics IncFLXN 1,302,844, disposed Open Form 4 filing 0001209191-15-055473
2015-06-19 S, Open-market sale Flexion Therapeutics IncFLXN 1,021,225, disposed Open Form 4 filing 0001209191-15-055473
2015-06-18 S, Open-market sale Flexion Therapeutics IncFLXN 767,903, disposed Open Form 4 filing 0001209191-15-055473
2015-05-11 P, Open-market purchase HTG Molecular Diagnostics, IncHTGM 5,111,484, acquired Open Form 4 filing 0001209191-15-041824
2015-05-11 P, Open-market purchase CoLucid Pharmaceuticals, Inc.CLCD 13,000,000, acquired Open Form 4 filing 0001209191-15-041823

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 609
  • Open-market sale 115
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Novo Holdings A/S, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001388325

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.